CBD Oil in MCT (30%)
CBD Oil in MCT (30%) Black is backordered and will ship as soon as it is back in stock.
CBD oil in MCT (30%)
Broad-spectrum cannabidiol produced in Switzerland
Our CBD oil dissolved in MCT oil is a broad-spectrum cannabidiol product of the highest quality, made from Swiss certified hemp. The product contains 30% CBD (3000 mg cannabidiol) and is completely THC-free. The combination of MCT oil and CBD has been developed to provide an effective and stable solution that is excellent for cosmetic use on the skin. Each bottle is equipped with a medical pipette for easy and accurate application.
Benefits and effects
CBD oil in MCT can help maintain healthy and balanced skin. MCT oil, known for its medium-length triglycerides, is easily absorbed and has a moisturizing effect, while supplying the skin with valuable fatty acids. When combined with broad-spectrum CBD, this oil can help relieve dryness, nourish the skin, and support the skin's natural defenses. The MCT oil also acts as a sustainable carrier of cannabidiol, increasing the stability and shelf life of the product.
This product is intended for cosmetic use
Ingredients and content
- Ingredients: MCT oil, CBD oil (broad spectrum cannabidiol, 3000 mg from Swiss hemp)
- Contents per bottle: 10 ml (approx. 270 drops)
- THC content: 0.0% - lab tested and confirmed THC free
Instructions for use
Shake the bottle well before use. Apply a few drops to the desired skin area morning and evening. We recommend that you start with a small amount, especially if you have no experience with CBD products. Store the product in a cool, dry place, out of direct sunlight, to preserve its quality.
Quality control and test results
All our products undergo a strict quality control. Our CBD oil is tested for cannabinoid content, microbiological safety, heavy metals and other potential contaminants in Swiss laboratories. In addition to ingredient control, we work with a British supplier of biodegradable packaging to ensure that the product is packaged with consideration for the environment. This is a pure product with no genetically modified ingredients, pesticides, herbicides or chemical residues, manufactured in accordance with Good Manufacturing Practices (CGMP) and Documentation Practices (GDP).
Reservation
For adults over 18 years of age. Not recommended for pregnant or lactating women without medical approval. This product is intended for cosmetic use and not for oral administration. Uno Vita AS makes no medical claims about the product's effects. Always consult a healthcare professional before use if you have medical conditions or are taking prescription medications.
Freedom of expression and right to information
Uno Vita reserves the right to share publicly available research and information on health and wellness technologies, natural substances, vitamins and the like in line with laws on freedom of expression. This includes:
- United Nations Universal Declaration of Human Rights (1948): Article 19
- The International Covenant on Civil and Political Rights (1966): Article 19
- Section 100 of the Norwegian Constitution
- America's First Amendment
Relevant references:
- Huestis, M.A. (2007). Human Cannabinoid Pharmacokinetics.
- Grotenhermen, F. (2003). Pharmacokinetics and pharmacodynamics of cannabinoids.
- Mechoulam, R., & Parker, L.A. (2013). The endocannabinoid system and the brain.
- Russo, E. B. (2011). Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
- Pertwee, R.G. (2006). Cannabinoid pharmacology.
- Pisanti, S., et al. (2017). Cannabidiol: State of the art and new challenges for therapeutic applications.
- McPartland, J.M., et al. (2015). Cannabidiol modulation of the endocannabinoid system.
- Zuardi, A.W. (2008). Cannabidiol: A drug with a wide spectrum of action.
- Pamplona, F.A., et al. (2018). The anti-inflammatory properties of cannabidiol.
- Shannon, S., et al. (2019). Cannabidiol in anxiety and sleep.
- Ashton, C.H. (2001). Effects of cannabis: A brief review.
- Pertwee, R.G., et al. (2018). Cannabinoids in health and disease.
